Physician profile
Ivan J Chavez
NPI 1417915158
$5,999.78
in general payments reported to CMS, 2019-2025
10 companies · $528 in 2025
The $528 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $933 · 2021: $131 · 2022: $1,479 · 2023: $163 · 2024: $2,650 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,906 · Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,906.13 |
| Food and Beverage | $1,434.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,918.41 | 2024-2025 | Onyx Frontier, Corevalve Evolut R, Viance |
| Abbott Laboratories | $1,401.48 | 2021-2025 | Diamondback Coronary, Esprit |
| Boston Scientific Corporation | $933.22 | 2020 | |
| Penumbra, INC. | $584.71 | 2024 | Indigo System |
| Abiomed | $499.04 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $180.10 | 2022 | |
| Gentuity, LLC | $176.25 | 2025 | Vis-Rx Prime, Gentuity Hf-Oct Imaging System |
| Heartflow, INC. | $163.37 | 2023 | Ffrct |
| Cathworks, INC. | $120.65 | 2024 | Ffrangio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.55 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Chavez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.